Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581.
A. P. Venook
Consultant or Advisory Role - Genomic Health (U); Myriad Genetics (U)
Research Funding - Genomic Health
D. Niedzwiecki
No relevant relationships to disclose
M. Lopatin
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
M. Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
P. N. Friedman
No relevant relationships to disclose
W. Frankel
No relevant relationships to disclose
K. Clark-Langone
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
C. Yoshizawa
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
C. Millward
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
S. Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
R. M. Goldberg
Consultant or Advisory Role - Genentech; Lilly
Research Funding - Abbott Laboratories; Amgen; Bayer; Bristol-Myers Squibb; Genentech
N. N. Mahmoud
No relevant relationships to disclose
R. L. Schilsky
Consultant or Advisory Role - Foundation Medicine
M. M. Bertagnolli
No relevant relationships to disclose